X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (156746) 156746
Newsletter (9447) 9447
Newspaper Article (1188) 1188
Dissertation (872) 872
Book Chapter (862) 862
Magazine Article (368) 368
Publication (167) 167
Book / eBook (97) 97
Conference Proceeding (88) 88
Web Resource (51) 51
Reference (37) 37
Book Review (34) 34
Government Document (6) 6
Journal / eJournal (6) 6
Transcript (4) 4
Paper (3) 3
Streaming Video (3) 3
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70247) 70247
animals (63856) 63856
male (55849) 55849
angiotensin (39298) 39298
female (35942) 35942
rats (35081) 35081
hypertension (27604) 27604
middle aged (20597) 20597
angiotensin-ii (19988) 19988
angiotensin-converting enzyme inhibitors - therapeutic use (18601) 18601
angiotensin ii (18364) 18364
angiotensin ii - pharmacology (17509) 17509
blood pressure - drug effects (17440) 17440
peripheral vascular disease (17227) 17227
adult (16351) 16351
renin-angiotensin system (16128) 16128
pharmacology & pharmacy (15444) 15444
aged (15185) 15185
cardiac & cardiovascular systems (15185) 15185
hypertension - drug therapy (13986) 13986
research (13631) 13631
blood pressure (13122) 13122
blood-pressure (12005) 12005
physiology (11489) 11489
mice (10398) 10398
hypertension - physiopathology (10280) 10280
expression (9297) 9297
angiotensin-converting enzyme (9296) 9296
rats, sprague-dawley (9260) 9260
angiotensin-converting enzyme inhibitors - pharmacology (8890) 8890
risk factors (8766) 8766
urology & nephrology (8586) 8586
biochemistry & molecular biology (8247) 8247
antihypertensive agents - therapeutic use (8064) 8064
oxidative stress (7808) 7808
heart failure (7530) 7530
cells, cultured (7506) 7506
renin-angiotensin system - drug effects (7504) 7504
renin - blood (7378) 7378
time factors (7227) 7227
enzymes (7169) 7169
angiotensin ii - metabolism (7124) 7124
analysis (7068) 7068
renin-angiotensin system - physiology (6895) 6895
dose-response relationship, drug (6838) 6838
renin (6795) 6795
physiological aspects (6732) 6732
endocrinology & metabolism (6640) 6640
treatment outcome (6389) 6389
medicine, general & internal (6206) 6206
rats, wistar (6067) 6067
mortality (5922) 5922
disease models, animal (5895) 5895
angiotensin receptor antagonists (5743) 5743
heart failure - drug therapy (5637) 5637
ace inhibitors (5512) 5512
angiotensin-converting enzyme inhibitors (5381) 5381
aldosterone (5380) 5380
activation (5355) 5355
angiotensin converting enzyme (5276) 5276
medicine, research & experimental (5231) 5231
cell biology (5223) 5223
inhibition (5212) 5212
captopril (5201) 5201
losartan (5131) 5131
diabetes (5091) 5091
system (5063) 5063
inflammation (5025) 5025
drug therapy, combination (4985) 4985
health aspects (4969) 4969
in vitro techniques (4960) 4960
heart (4788) 4788
kidney (4730) 4730
angiotensin ii - physiology (4718) 4718
receptor (4646) 4646
dogs (4571) 4571
proteins (4548) 4548
hypertrophy (4543) 4543
antihypertensive agents - pharmacology (4529) 4529
disease (4499) 4499
fibrosis (4494) 4494
angiotensin ii type 1 receptor blockers - therapeutic use (4359) 4359
heart-failure (4359) 4359
angiotensin ii - blood (4337) 4337
signal transduction (4334) 4334
myocardial-infarction (4302) 4302
adrenergic beta-antagonists - therapeutic use (4286) 4286
kidney - drug effects (4278) 4278
rat (4231) 4231
nitric oxide (4222) 4222
hypertension - complications (4216) 4216
care and treatment (4154) 4154
blood pressure - physiology (4127) 4127
drug therapy (4091) 4091
angiotensin-converting enzyme inhibitors - adverse effects (4087) 4087
nitric-oxide (4050) 4050
receptors (4045) 4045
cells (4012) 4012
rats, inbred strains (4012) 4012
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (55) 55
Online Resources - Online (41) 41
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Periodical Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (158665) 158665
Japanese (3615) 3615
German (2684) 2684
French (2018) 2018
Russian (1793) 1793
Chinese (1210) 1210
Spanish (1121) 1121
Portuguese (818) 818
Italian (769) 769
Polish (538) 538
Korean (242) 242
Czech (192) 192
Hungarian (140) 140
Danish (119) 119
Dutch (118) 118
Swedish (96) 96
Romanian (87) 87
Norwegian (74) 74
Turkish (66) 66
Slovak (61) 61
Ukrainian (49) 49
Finnish (44) 44
Hebrew (33) 33
Bulgarian (29) 29
Serbian (28) 28
Croatian (19) 19
Persian (19) 19
Lithuanian (13) 13
Slovenian (8) 8
Bosnian (4) 4
Belarusian (1) 1
Indonesian (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of gastroenterology and hepatology, ISSN 1440-1746, 2008, Volume 23, Issue 9, pp. 1327 - 1338
The renin–angiotensin system (RAS) is a key regulator of vascular resistance, sodium and water homeostasis and the response to tissue injury. Historically,... 
hepatic fibrosis | angiotensin converting enzyme 2 | renin–angiotensin system | angiotensin (Ang)‐(1–7) | Hepatic fibrosis | Angiotensin converting enzyme 2 | Angiotensin (Ang)-(1-7) | Renin-angiotensin system | angiotensin (Ang)-(1-7) | FIBROSIS DEVELOPMENT | II RECEPTOR ANTAGONIST | ACE-INHIBITOR | CONVERTING ENZYME-INHIBITORS | TYPE-1 RECEPTOR | RENAL HEMODYNAMICS | HEPATIC STELLATE CELLS | PORTAL PRESSURE | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | renin-angiotensin system | ANTIHYPERTENSIVE ACTIONS | Proto-Oncogene Proteins - metabolism | Kinins - metabolism | Peptide Fragments - metabolism | Liver - enzymology | Angiotensin II - metabolism | Receptors, G-Protein-Coupled - metabolism | Angiotensin I | Humans | Liver - metabolism | Liver - physiopathology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Animals | Hypertension, Portal - metabolism | Liver Cirrhosis - metabolism | Peptidyl-Dipeptidase A - metabolism | Angiotensins - metabolism | Renin-Angiotensin System - drug effects | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Liver Diseases - physiopathology | Liver Diseases - metabolism | Kallikreins - metabolism | Renin-Angiotensin System, drug effects | Proto-Oncogene Proteins, metabolism | Angiotensin II Type 1 Receptor Blockers, pharmacology | Kallikreins, metabolism | Liver Cirrhosis, metabolism | Kinins, metabolism | Liver Diseases, physiopathology | Liver, metabolism | Liver Diseases, metabolism | Renin-Angiotensin System | Hypertension, Portal, metabolism | Liver, enzymology | Liver, physiopathology | Receptors, G-Protein-Coupled, metabolism | Angiotensin-Converting Enzyme Inhibitors, pharmacology | Angiotensin II, metabolism | Angiotensins, metabolism | Peptide Fragments, metabolism | Peptidyl-Dipeptidase A, metabolism | Liver diseases | Peptide hormones | Angiotensin converting enzyme | Angiotensin | Basic Science of Gastroenterology and Hepatology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 3, pp. 211 - 221
Journal Article
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1368, pp. 231 - 238
Abstract Sleep apnea is characterized by increased sympathetic activity and is associated with systemic hypertension. Angiotensin (Ang) peptides have... 
Neurology | Intermittent hypoxia | Hypertension | Renin–angiotensin system | Sympathetic activity | Angiotensin-(1–7) | Renin-angiotensin system | Angiotensin-(1-7) | HEART-FAILURE | AWAKE RATS | CHEMOREFLEX ACTIVATION | NEUROSCIENCES | BLOOD-PRESSURE | CHRONIC-INTERMITTENT HYPOXIA | CARDIOVASCULAR REGULATION | ROSTRAL VENTROLATERAL MEDULLA | SYMPATHETIC-NERVE ACTIVITY | NITRIC-OXIDE | EPISODIC HYPOXIA | Sleep Apnea Syndromes - physiopathology | Angiotensin II - administration & dosage | Angiotensin Receptor Antagonists - pharmacology | Imidazoles - administration & dosage | Male | Peptide Fragments - pharmacology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 2 Receptor Blockers - pharmacology | Hypertension - etiology | Hypertension - prevention & control | Blood Pressure - drug effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Disease Models, Animal | Angiotensin II - pharmacology | Pyridines - administration & dosage | Microinjections | Peptide Fragments - administration & dosage | Losartan - pharmacology | Rats | Imidazoles - pharmacology | Angiotensin II - analogs & derivatives | Rats, Sprague-Dawley | Sleep Apnea Syndromes - complications | Paraventricular Hypothalamic Nucleus - drug effects | Animals | Angiotensin II Type 2 Receptor Blockers - administration & dosage | Pyridines - pharmacology | Losartan - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Neurons | Carbon dioxide | Antagonists | Hypothalamus | Paraventricular nucleus | Muscimol | Sympathetic nervous system | Telemetry | Angiotensin receptors | Sleep disorders | Apnea | gamma -Aminobutyric acid A receptors | Angiotensin | Hypoxia | Blood pressure | cardiovascular regulation | peptides: anatomy and physiology | sympathetic activity | angiotensin-(1-7) | hypothalamic-pituitary-adrenal regulation | intermittent hypoxia | hypertension | renin-angiotensin system
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
MEDICINE, GENERAL & INTERNAL | STRUCTURAL-FUNCTIONAL RELATIONSHIPS | CORTICAL INTERSTITIUM | BLOOD-PRESSURE CONTROL | EARLY NATURAL-HISTORY | RETINOPATHY | RECEPTOR | ANGIOTENSIN-CONVERTING ENZYME | NEPHROPATHY | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Trends in Cardiovascular Medicine, ISSN 1050-1738, 2015, Volume 26, Issue 3, pp. 221 - 228
Abstract Angiotensin II, an important component of renin angiotensin system, is a potent vasopressor and its actions are mostly mediated via angiotensin II... 
Cardiovascular | Heart failure | Hypertension | Renin angiotensin system | Angiotensin receptor blocker | Diabetes mellitus | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTAGONIST | CLINICAL-TRIAL | HEART-FAILURE | DIABETIC-NEPHROPATHY | HYPERTENSIVE PATIENTS | AZILSARTAN MEDOXOMIL | FIMASARTAN | OLMESARTAN | IRBESARTAN | VALSARTAN | Kidney Diseases - physiopathology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Heart Diseases - metabolism | Kidney - pathology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Receptor, Angiotensin, Type 2 - drug effects | Kidney - metabolism | Drug Interactions | Myocardium - metabolism | Receptor, Angiotensin, Type 1 - drug effects | Drug Therapy, Combination | Kidney Diseases - metabolism | Heart - physiopathology | Kidney - drug effects | Angiotensin II - metabolism | Heart Diseases - physiopathology | Kidney Diseases - drug therapy | Treatment Outcome | Angiotensin II Type 2 Receptor Blockers - adverse effects | Angiotensin II Type 2 Receptor Blockers - therapeutic use | Animals | Receptor, Angiotensin, Type 2 - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Heart - drug effects | Renin-Angiotensin System - drug effects | Heart Diseases - drug therapy | Heart | Pharmacy | Angiotensin converting enzyme | Atherosclerosis | Angiotensin | Physiological aspects | Patient compliance | Studies | Cardiac arrhythmia | Advantages | Cardiomyopathy | Mortality | Inflammation | Diabetes | Kidney diseases | Metabolism
Journal Article
Journal of the renin-angiotensin-aldosterone system, ISSN 1470-3203, 2000
Journal